Promise Details
Following review of neurodevelopmental risk studies, Kennedy ordered FDA to update pregnancy-warning labels on acetaminophen products. The decision aimed at transparency without restricting access. Pharma groups opposed the change, claiming weak evidence; advocacy groups welcomed acknowledgment of risk. Updated labeling entered Federal Register publication in May 2025.
What was done
FDA issued new pregnancy-warning labeling for acetaminophen as announced by Kennedy; policy implemented.
Sources
The information presented in this promise is aggregated from various publicly available sources. We do not claim ownership or guarantee the accuracy of the content. All data is collected and cross-validated from multiple independent sources. To read more about this promise, please view the source links below:
Support Our Work
Help us keep the website running and free for everyone by supporting us:
